SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
12-Jun-24 4:30 PM View: | Biomea Fusion, Inc. (BMEA) | 11-Jun-24 | Purchase | 12,509 | $4.43 | $55,361.10 | 42% 29.99K to 42.5K | |
12-Jun-24 4:30 PM View: | Biomea Fusion, Inc. (BMEA) | 31-May-24 | Grant | 4,448 | $3.78 | $16,824.60 | 17% 25.54K to 29.99K | |
01-Dec-23 5:58 PM View: | Biomea Fusion, Inc. (BMEA) | 30-Nov-23 | Grant | 1,345 | $3.78 | $5,087.46 | 6% 24.2K to 25.54K | |
02-Jun-23 5:01 PM View: | Biomea Fusion, Inc. (BMEA) | 31-May-23 | Grant | 4,273 | $3.78 | $16,162.60 | 21% 19.93K to 24.2K | |
02-Dec-22 10:00 PM View: | Biomea Fusion, Inc. (BMEA) | 30-Nov-22 | Grant | 2,518 | $3.78 | $9,524.33 | 14% 17.41K to 19.93K | |
14-Nov-22 4:30 PM View: | Biomea Fusion, Inc. (BMEA) | 11-Nov-22 | Market Purchase | 4,100 | $7.63 | $31,285.90 | 31% 13.31K to 17.41K | (2%) |
01-Jun-22 6:00 PM View: | Biomea Fusion, Inc. (BMEA) | 31-May-22 | Grant | 3,307 | $4.67 | $15,432.10 | 33% 10.0K to 13.31K | |
18-Jan-22 7:00 PM View: | Biomea Fusion, Inc. (BMEA) | 14-Jan-22 | Purchase | 10,000 | $8.68 | $86,767.00 | 100% 0 to 10.0K | |
13-Jan-21 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 12-Jan-21 | Option Exercise | 1,747 | $7.24 | $12,648.30 | 100% 0 to 1.75K | |
13-Jan-21 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 12-Jan-21 | Market Option Sale | 1,747 | $125.44 | $219,152.00 | (100%) 1.75K to 0 | (2%) |
13-Jan-21 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 11-Jan-21 | Option Exercise | 1,500 | $7.24 | $10,860.00 | 100% 0 to 1.5K | |
13-Jan-21 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 11-Jan-21 | Market Option Sale | 1,500 | $125.61 | $188,408.00 | (100%) 1.5K to 0 | (2%) |
10-Nov-20 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 09-Nov-20 | Option Exercise | 1,623 | $7.24 | $11,750.50 | 100% 0 to 1.62K | |
10-Nov-20 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 09-Nov-20 | Market Option Sale | 1,623 | $74.93 | $121,609.00 | (100%) 1.62K to 0 | (71%) |
09-Oct-20 5:23 PM View: | Eidos Therapeutics, Inc. (EIDX) | 08-Oct-20 | Option Exercise | 5,199 | $7.24 | $37,640.80 | 100% 0 to 5.2K | |
09-Oct-20 5:23 PM View: | Eidos Therapeutics, Inc. (EIDX) | 08-Oct-20 | Market Option Sale | 4,755 | $74.85 | $355,917.00 | (91%) 5.2K to 0.44K | (72%) |
09-Oct-20 5:23 PM View: | Eidos Therapeutics, Inc. (EIDX) | 08-Oct-20 | Market Sale | 444 | $74.85 | $33,233.90 | (100%) 0.44K to 0 | (72%) |
09-Oct-20 5:23 PM View: | Eidos Therapeutics, Inc. (EIDX) | 07-Oct-20 | Option Exercise | 5,000 | $7.24 | $36,200.00 | 1126% 0.44K to 5.44K | |
09-Oct-20 5:23 PM View: | Eidos Therapeutics, Inc. (EIDX) | 07-Oct-20 | Market Option Sale | 5,444 | $75.08 | $408,748.00 | (100%) 5.44K to 0 | (71%) |
05-Jun-20 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 31-May-20 | Grant | 444 | $41.57 | $18,458.60 | 100% 0 to 0.44K | |
22-Apr-20 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 20-Apr-20 | Option Exercise | 2,000 | $7.24 | $14,480.00 | 100% 0 to 2.0K | |
22-Apr-20 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 20-Apr-20 | Market Option Sale | 2,000 | $49.79 | $99,580.00 | (100%) 2.0K to 0 | (158%) |
30-Mar-20 4:23 PM View: | Eidos Therapeutics, Inc. (EIDX) | 26-Mar-20 | Option Exercise | 5,000 | $7.24 | $36,200.00 | 100% 0 to 5.0K | |
30-Mar-20 4:23 PM View: | Eidos Therapeutics, Inc. (EIDX) | 26-Mar-20 | Market Option Sale | 5,000 | $48.26 | $241,310.00 | (100%) 5.0K to 0 | (166%) |
04-Mar-20 4:08 PM View: | Eidos Therapeutics, Inc. (EIDX) | 02-Mar-20 | Option Exercise | 3,000 | $7.24 | $21,720.00 | 100% 0 to 3.0K | |
04-Mar-20 4:08 PM View: | Eidos Therapeutics, Inc. (EIDX) | 02-Mar-20 | Market Option Sale | 3,000 | $52.33 | $156,980.00 | (100%) 3.0K to 0 | (145%) |